%0 Meta-Analysis
%T Diagnostic accuracy of HIK1083 and MUC6 as immunohistochemical markers of endocervical gastric-type adenocarcinoma: A systematic review and meta-analysis.
%A Fulgione C
%A Raffone A
%A Travaglino A
%A Arciuolo D
%A Santoro A
%A Cianfrini F
%A Russo D
%A Varricchio S
%A Raimondo I
%A Inzani F
%A Mollo A
%A Guida M
%A Mascolo M
%A Zannoni GF
%J Pathol Res Pract
%V 241
%N 0
%D Jan 2023
%M 36527837
%F 3.309
%R 10.1016/j.prp.2022.154261
%X <B>BACKGROUND: </B>HIK1083 and MUC6 have been used as immunohistochemical markers to differentiate gastric-type adenocarcinoma (GTAC) from other endocervical adenocarcinomas. We aimed to assess their diagnostic accuracy through a systematic review and meta-analysis.<BR><B>METHODS: </B>Three electronic databases were searched from their inception to July 2022 for all studies assessing the expression in endocervical GTAC vs other endocervical adenocarcinomas. Diagnostic accuracy was assessed as sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), diagnostic odds ratio (DOR), and area under the curve (AUC) on SROC curves.<BR><B>RESULTS: </B>Four studies with 343 patients were included. HIK1083 showed sensitivity= 0.64, specificity= 0.94, LR+ =8.30, LR-= 0.38, DOR= 33.36, AUC= 89.9%. MUC6 showed sensitivity= 0.51, specificity= 0.74, LR+ =1.96, LR-= 0.71, DOR= 3.48, AUC= 72.8%.<BR><B>CONCLUSIONS: </B>HIK1083 showed high specificity and low sensitivity as a marker of GTAC, with moderate overall accuracy; MUC6 showed moderate specificity and low sensitivity, with low overall accuracy.